Posts Tagged ‘opioids’

FDLI Conference on REMS: Benefits and Risks Meet Liabilities and Opportunities

Wednesday, February 24th, 2010

- Guest blog by Roger Morris, The LondonBritian Company -

You’ve heard all the analogies:  Is the glass half empty or half full?  Does the dark storm cloud have a silver lining?

I was constantly reminded of this during the Food & Drug Law Institute’s latest conference on REMS held February 16 in Washington, D.C., as the residents and transportation system was trying to dig out of one-two snowstorms.  It was an interesting conference, one that built substantially on the groundwork done at last year’s REMS conference which the FDLI co-hosted with ParagonRx. (more…)